Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.600 Biomarker disease BEFREE PPARα contributes to the CYP2A5 protective effects on fatty liver but it opposes to the protective effects on obesity. 29568101 2019
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.600 GeneticVariation disease BEFREE Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosis. 16297361 2005
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.600 Biomarker disease BEFREE During the development of hepatic steatosis (8-16 weeks), PPARα was activated as indicated by its target genes as well as the elevated peroxisomal acyl-CoA oxidase activity. 30120929 2018
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.600 Biomarker disease BEFREE Supplementation with Docosahexaenoic Acid and Extra Virgin Olive Oil Prevents Liver Steatosis Induced by a High-Fat Diet in Mice through PPAR-α and Nrf2 Upregulation with Concomitant SREBP-1c and NF-kB Downregulation. 28940752 2017
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.600 Biomarker disease BEFREE Novel PPARα agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging. 28545035 2017
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.600 AlteredExpression disease BEFREE SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis. 20033348 2010
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.600 Biomarker disease BEFREE HIV-1 viral protein R (Vpr) induces fatty liver in mice via LXRα and PPARα dysregulation: implications for HIV-specific pathogenesis of NAFLD. 29042644 2017
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.600 AlteredExpression disease BEFREE Thus, resistance of Pin1 KO mice to hepatic steatosis is partially attributable to the lack of Pin1-induced down-regulation of peroxisome proliferator-activated receptor α, although multiple other mechanisms are apparently involved. 23112047 2012
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.600 Biomarker disease BEFREE Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes. 25605057 2015
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.600 Biomarker disease BEFREE Activating AMPK<i>α</i> negatively regulates Egr1 to inhibit inflammatory cytokines in high glucose. miR-34a inhibition increases phosphorylated AMPK<i>α</i> through mediating SIRT1 to suppress the development of fatty liver. 29681936 2018
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.600 Biomarker disease BEFREE Several in vitro and in vivo studies have shown the known protective effects of SIRT1 activators, such as resveratrol and SRT1720, on diabetes- or obesity-induced fatty liver and insulin resistance. 29402742 2018
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.600 Biomarker disease BEFREE Retinoic acid ameliorates high-fat diet-induced liver steatosis through sirt1. 28667519 2017
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.600 PosttranslationalModification disease BEFREE Paternal hyperglycemia induces transgenerational inheritance of susceptibility to hepatic steatosis in rats involving altered methylation on Pparα promoter. 30404040 2019
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.600 Biomarker disease BEFREE We are the first to demonstrate that the SIRT1/HMGB1 pathway is a key therapeutic target for controlling NAFLD inflammation and that SalB confers protection against HFD- and PA-induced hepatic steatosis and inflammation through SIRT1-mediated HMGB1 deacetylation. 26525891 2015
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.600 Biomarker disease BEFREE These results demonstrate that RSV restored leptin sensitivity in a cellular model of hepatic steatosis in a SIRT1-independent manner. 31842467 2019
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.600 GeneticVariation disease BEFREE Adenovirus-mediated liver-specific expression of SIRT1 or a phosphor-defective S164A-SIRT1 mutant promoted fatty acid oxidation and ameliorated liver steatosis and glucose intolerance in diet-induced obese mice, but these beneficial effects were not observed in mice expressing a phosphor-mimic S164D-SIRT1 mutant. 28533219 2017
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.600 AlteredExpression disease BEFREE Hepatic miR-141 and miR-200c RNA levels were highly induced in human patients with NASH fatty liver and in WT MCD mice. miR-141/200c-/- MCD mice had reduced liver weights and triglyceride (TG) levels, which was associated with increased microsomal TG transfer protein (MTTP) and PPARα but reduced SREBP1c and FAS expression. 29093267 2017
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.600 AlteredExpression disease BEFREE Circulating WISP-1/CCN4 positively correlated with body mass index, body fat percentage, leptin and triglyceride levels, hip circumference and fatty liver index. 29129025 2018
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.600 Biomarker disease BEFREE Leptin improved the fatty liver possibly by activating hepatic AMPK through the central and sympathetic nervous systems. 23024365 2012
Entrez Id: 5465
Gene Symbol: PPARA
PPARA
0.600 AlteredExpression disease BEFREE Aged and Zmpste24-deficient livers share several features, including nuclear lamina abnormalities, increased Foxa2 binding, de-repression of PPAR- and LXR-dependent gene expression, and fatty liver. 29484800 2018
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.600 Biomarker disease BEFREE We found significant associations between increasing maternal prepregnancy BMI, being born large for gestational age, offspring level of sCD163, as well as offspring metabolic risk factors (decreasing adiponectin and HDL cholesterol and increasing leptin, HOMA of insulin resistance, and HOMA of insulin secretion) and degree of fatty liver. 31167890 2019
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.600 Biomarker disease BEFREE Epigallocatechin-3-Gallate-Rich Green Tea Extract Ameliorates Fatty Liver and Weight Gain in Mice Fed a High Fat Diet by Activating the Sirtuin 1 and AMP Activating Protein Kinase Pathway. 29595075 2018
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.600 Biomarker disease BEFREE Aging is a significant risk factor for the development of obesity and hepatic steatosis associated with insulin and leptin resistance. 29575696 2018
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.600 Biomarker disease BEFREE Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathway. 30214535 2018
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.600 Biomarker disease BEFREE High-fat diet (60% kcal) was used to induce fatty liver phenotype with parallel insulin and leptin resistance. 29660503 2018